In medical devices, quality systems are often developed over years rather than days; they normally develop gradually, as a company grows with respect to products, manufacturing volume, suppliers and regulatory complexities. What works well initially (spreadsheets, email approvals, and shared departmental knowledge) begins to fail with respect to delays and inconsistencies. Quality groups spend increasing amounts of time finding documents, comparing document revisions, validating signatures, and determining if action was taken to meet requirements. Manufacturing managers observe the negative impacts of the poor performance of the quality group’s systems by seeing slower releases, longer investigation times, poorly coordinated changes, and increasing levels of administrative burdens. As such, an appropriately scaled quality system is not merely an IT enhancement, but a necessary component of organizations growing in size and complexity without losing control.
Companies involved in the manufacture of medical devices face this problem with particular intensity due to the fact that growing creates both opportunities and risks associated with regulations. For example, establishing an international facility or contract manufacturer represents both an opportunity for sales and potential for additional regulatory compliance exposures. Each type of addition requires either new documentation for each activity, new relationships between quality records (e.g., between the activities of the contract manufacturer and those within your company), or both. With every addition to the operation there exists multiple places where the lack of complete information or unconnectedness of process elements represent a potential source of compliance risk. Organizations dependent upon manual coordination methods may find that their staffing needs increase proportionally to the growth of operational complexity. This relationship is expensive to manage and produces inconsistent results when key personnel leave the organization. An appropriately scaled quality model attempts to break this relationship by creating processes that are more structured, interconnected, traceable, and reproducible.
Effective quality models are based upon the premise that organizations will inevitably become more complex as they grow. These models contain mechanisms for controlling the volume of quality-related records produced during growth without diminishing visibility into who owns them, what their status is, what evidence supports their existence, or what level of risk they represent. Additionally these models enable the reproduction of quality processes across different teams, departments, suppliers, and product lines. Because standardization provides value by reducing the number of manual interpretations required from employees regarding exceptions to rules, standardization is valued more highly. Similarly because automation provides value by enabling routine coordination tasks without requiring additional layers of administrative work, automation is also valued more highly.
Transitioning from Isolated Quality Management into Integrated Operations
Typically quality management programs mirror the company’s internal organizational structure. This means document control data is stored in a particular database or document repository; employee training records are stored in a different location (e.g., HR), supplier information is stored in a spreadsheet; and corrective actions are documented separately using either a specific software tool or a common shared folder. In terms of each individual process, there does not appear to be anything wrong with them individually. However, due to the lack of connectivity among the various databases storing the above types of quality-related information, finding the desired information within the larger enterprise is very challenging. Therefore employees need to have an understanding of where all their needed quality related information resides, which versions of documents represent the most current information and what other quality-related documents they should refer to prior to making any quality-related decision. As the size of the organization increases, the reliance upon corporate knowledge becomes much more tenuous. On the other hand, a scalable quality program views documents, processes, evidence, responsibilities and product-related information as part of a unified operating environment.
As manufacturers move away from fragmented quality administration, technology choices are becoming more consequential. Generic document repositories can digitize tasks, but they are not always built to preserve the traceability, controlled workflows, regulatory context, and product relationships required in medical device operations. That gap is increasing the demand for purpose-built MedTech platforms that connect quality management with product development and regulatory execution. Platforms such as Enlil, which applies agentic AI to traceability and regulated workflows, reflect this shift toward connected quality infrastructure. Its integrated quality management capabilities provide one example of how these functions can be structured, while the company’s discussion of digitizing quality operations offers additional context for manufacturers. The broader shift is toward systems that connect requirements, evidence, decisions, and downstream actions without adding unnecessary administrative complexity.
The ultimate goal of transitioning from isolated quality management programs into more integrated quality management programs is to establish a quality system that supports seamless communication across departments, teams and locations throughout the organization regarding quality related requirements, evidence, decisions and subsequent actions. Connected quality operations create value because information flows through work processes with minimal interpretation and fewer hand-offs. For example, a change request can be electronically linked to relevant procedures impacted, product specifications and descriptions, risk assessments associated with proposed changes, employee training requirements to perform new work instructions, validation testing results supporting new equipment or software, and historical documentation of implementation. A non-conformance report (NCR) can initiate investigations, escalate concerns, generate corrective actions and track effectiveness reviews without requiring users to manually recreate a timeline based upon emails. Similarly, a problem identified at the time of receiving goods-in from suppliers can automatically link together purchase orders and invoices associated with those purchases, inspection reports documenting deficiencies found during physical inspections, approved supplier qualifications and performance records, corrective actions taken by suppliers to address previous deficiencies, and purchasing decisions made after evaluating responses received from suppliers. Establishing electronic links among these types of quality-related information enables better visibility of the entire quality environment to managers; therefore reducing the potential for critical dependencies to be missed. More importantly, these connections enable a quality management system to act as an operational network as opposed to merely being a collection of archival documents.
Developing the Structure of a Scalable Quality Process
A scalable quality process starts with designing your quality process architecture (how you perform quality) versus just selecting a piece of software. Prior to making a decision on what type of quality process you will use; companies need to decide how quality related issues are raised, viewed, approved, escalated, resolved, and stored. As such, each process needs to have identified ownership, entry criteria, predictable status changes, and defined expectations for the types of supporting documentation required.
Quality approval chains should be designed based upon risk and accountability instead of old habits that include signatures for no reason other than to add them. Companies must control exceptions as each exception represents another workflow and adds training costs, increases the number of possible configurations for the system, and creates potential inconsistencies in workflow execution. Once you establish a well-defined process architecture for your quality operations, you provide technology with a solid foundation to build automation and reporting off of.
As many companies begin to transition away from disparate quality programs, the technology used in these areas has become much more important. Document repository tools can certainly help automate certain aspects of your quality program; however, there are several limitations associated with generic document repository tools including the ability to maintain a history of who was involved with a particular issue (traceability), ensure the proper flow of work through various stages within your quality process (controlled workflows), capture the regulatory compliance considerations applicable to a medical device (regulatory context), and track the relationship between the product being manufactured and the quality issue being addressed (product relationship). These limitations are driving greater demand for specialized Medical Technology (MedTech) platforms that integrate quality management with both product development and regulatory execution. One company addressing this area is Enlil which utilizes agentive artificial intelligence (AI) to enhance traceability and regulated workflows. Companies can utilize Enlil’s connected quality management capabilities as an example of structured quality infrastructure while their perspective on utilizing digital quality operations for medical device manufacturing provides additional insight. Overall, we see a larger trend toward connecting requirements, evidence, decisions, and subsequent actions throughout all regulated areas of operation without creating excessive internal administrative burdens.
Additionally, the architecture should allow for controlled variability without requiring each business unit to operate under a single structure. For instance, a multi-product class or multi-facility company may have legitimate reasons for requiring different review paths, risk levels or regional controls. In order to achieve scalability it is not necessary to eliminate variability but rather identify what variability is truly needed versus unnecessary customizations. While core processes can remain consistent (standardized), configurable rules can then be applied to address variations associated with specific products, locations or regulations. This design allows the system to remain simple while providing enough flexibility to accommodate real operational differences. Ultimately, the goal is to develop a common quality framework that becomes stronger as your company grows versus continues to fragment.
The quality function needs to know how the quality system relates to all product and manufacturing records. Not just “what” happened, but “which requirements”, “components”, “processes”, “suppliers”, “documents”, “tests”, “risks”, and “decisions”. Relating these pieces together can be an additional investigative effort when they reside within different systems. To assemble evidence in a structured manner, quality professionals will invest hours of their time relating information that could have been linked at the time of collection. With increased product design and manufacturing change, the difficulty increases.
Reliable scalable traceability makes the job easier by creating the links (relationships) between related records, allowing users to quickly access them across the product development and manufacturing life cycle.
When design and manufacturing team members have the ability to follow quality-related information along with the product, instead of having it siloed in departmental-based repository’s; the quality-related implications of a design change impacting the product’s critical dimensions are easily determined. The quality-related implication of a design change is to update manufacturing instruction, inspection criteria, risk controls, supplier specification, validation evidence and employee training. When each dependency is managed separately, implementing the design change can be inconsistent and difficult to validate. A scalable quality system provides the means to identify impacted quality records and responsibility during the change process. Reviewers get a clear picture of potential downstream effects prior to approving the design change. Visibility to downstream effects provides better decision making and decreases the likelihood of incomplete implementation of a design change.
In addition to providing benefits to manufacturers who implement scalable traceability, traceability also helps companies respond quicker to issues that arise after products leave the factory floor. Issues such as customer complaints or manufacturing non-conformances can be quickly analyzed using the applicable device configuration, supplier history, risk assessments, process controls, previous deviation occurrences and corrective actions. By identifying patterns that would likely go undetected without the use of consistent identifiers and relationships between records, investigators will have more time to evaluate causes of issues rather than spending most of their time gathering basic contextual information. By linking records together in a scalable fashion, management will also have more confidence in determining if an issue is isolated or potentially systemic.
Improving Corrective Action (CAPA), Deviation/Non-Conformance, Changes and Supplier Quality Processes
Typically as a company manufactures more devices, there is an increase in the number of deviations/complaints/non-conformances/audit findings/supplier issues/internal observations. An unplanned/uncontrolled proliferation of CAPAs can create too much administrative overhead and obscure true systemic issues. Additionally, underutilizing CAPA can result in significant recurring issues going unnoticed by senior management. A scalable quality system should enable teams to consistently classify events, assess risk/recurrence and determine when formal corrective action is warranted. It should bring attention to systemic issues and not allow administrative volume to overwhelm quality personnel.
The process for managing non-conformances should also be similarly disciplined and should link directly with investigations/dispositions/suppliers/CAPA. Production staff should have a simple way to record what happened/where/how much material/product was involved/what immediate actions were taken to contain. Quality reviewers should have enough context to determine if an incident can be disposed of locally or if further investigation is warranted. Defect trends/recurring defect code/process steps/components/suppliers should be apparent via trending as opposed to being based upon anecdotal knowledge. Structured information will facilitate quicker management review and more consistent escalation. When volumes of manufactured parts increase significantly, these capabilities will keep quality events from becoming an unmanageable queue of unrelated records.
Supplier Quality Becomes Important Because Most Companies Use Suppliers for Much of Their Raw Materials and/or Services
Most large-scale manufacturers rely heavily on an increasing array of outside suppliers. Therefore, it is essential that approved suppliers are properly qualified, monitored, reviewed periodically and managed according to the risks associated with the materials/services supplied by each supplier. Supplier corrective actions should be tied into findings from receiving inspection/tests/manufacturing failures/audits/purchasing decisions. Supplier performance metrics should enable teams to distinguish intermittent variability from declining quality performance over time. Change notices from suppliers should also be entered into internal change-control procedures whenever product or process impacts exist. A connected system transforms supplier management from a periodic administrative exercise into a continuous part of manufacturing risk management.
Sustaining Compliance Readiness During Rapid Growth
Compliance readiness is usually considered a periodic preparation activity for audits/inspections. However, as an organization expands, preparing for audits/inspections can grow exponentially in terms of scope (number of processes/documents/etc.) requiring review. Before an audit/inspection begins, teams can take weeks reviewing training completion status/document approvals/CAPA statuses/supplier files/validation records etc., prior to an external assessment. Although this initial surge of preparation may temporarily restore order, it clearly indicates that regular business practices do not produce satisfactory levels of compliance visibility. A scalable quality system should promote compliance readiness as a routine state-of-being versus an emergency preparedness project every few months. A quality system should ensure that records are complete, controlled/attributable/retrievable as a direct result of performing daily tasks.
For a company to establish compliance readiness continuously, it must adhere to workflow disciplines. Employees should not circumvent required approvals simply because a deadline is looming and overdue activities should be evident well-before they represent a systemic exposure. Training assignments should automatically occur when controlled documents are revised as opposed to depending on individuals to coordinate manually. Reviews should be performed at predetermined intervals on a schedule established across all departments. Follow up activities relative to CAPA effectiveness checks etc. should remain viewable until sufficient evidence is generated. These mechanisms minimize reliance on personal memories and permit upper level management intervention prior to small delays developing into audit findings.
Additionally, compliance readiness in a scalable fashion requires finding balance between control measures. While an overly complex system can lead employees to utilize workarounds/develop unauthorized spreadsheets/postpone documentations due to the excessiveness of formalized processes; excessive complexity can ultimately compromise the compliance purposes that it originally sought to serve. Designing user-friendly workflows that capture requisite evidence while minimizing redundant data entry/approval cycles is essential in promoting compliance readiness and user adoption. The best compliance environment is one in which disciplined behaviors are also the simplest form of operation for users across engineering/manufacturing/quality/regulatory/supply chain and leadership roles.
Quality systems must provide a form of management insight — as opposed to simply record keeping — to be considered scalable. While medical devices generate vast amounts of data related to quality (deviations, CAPAs, complaints, etc.), much of this information is siloed and only examined when there is a specific problem. Collectively, these types of aggregated quality data can provide insight into when risk within an operation is growing prior to a major failure occurring. Additionally, quality data can show if corrections are actually improving the rate of recurrences versus just closing out administrative records.
Therefore, quality metrics become more valuable when they are tied to the processes and evidence that produced the original data. Management Dashboards should focus on decision quality rather than quantity of available indicators. Indicators like overdue CAPAs, non-conforming items, investigation cycle times, supplier defect rates, change implementations, training completions, audit observations and complaint frequencies are examples of the type of signals that can provide some level of insight. Each indicator should have a defined purpose, assigned owner and expected management response. An indicator that degrades over a long period of time without triggering some management response is nothing more than “window dressing.”
In addition to understanding what each indicator represents, leaders should also differentiate between Activity Measures and Outcome Measures. Closing more records does not always equate to better quality. The primary goal of using data is to identify risk; improve processes; and allocate resources more effectively.
When organizations have multiple product lines or manufacturing sites; the ability to perform site comparisons on investigation cycles, defect recurrence rates, supplier performance, compliance with process requirements, etc., can highlight where additional support may be required. Analyzing product lines can assist in identifying if certain product designs or components are resulting in higher quality costs. In addition, tracking trends will assist managers in reviewing the effectiveness of the quality system over time. With proper structuring of data; quality management can become more proactive and less reactive to problems after they occur.
Building Governance and Operational Models to Support Long-term Growth
While technology has made significant strides in enabling scalability of quality systems; governance still plays a key role in defining how those technologies will be utilized throughout the organization. For example, all major processes require someone to be accountable for policy development, performance measurement, establishing metrics, handling exceptions and driving continuous improvement. Additionally, local teams need to understand what aspects of a process can be tailored to meet local needs versus what must remain constant throughout the company. Allowing different departments to implement changes based upon their own individual needs will result in a complex web of processes and tools throughout the organization. Establishing strong governance ensures consistency as the number of users, products, facilities and processes increase.
Roles and Responsibilities should also be defined with consideration given to the operational realities as opposed to job titles alone. Quality teams are typically responsible for developing frameworks; however, successful execution of these frameworks depend heavily on engagement from Engineering, Manufacturing, Regulatory Affairs, Supply Chain, Operations and Leadership. Process Owners should know the evidence that is expected from them and the timelines for completing those responsibilities. Clear escalation paths should exist when activities become overdue or when risk exceeds predetermined thresholds. Leadership should be able to quickly identify significant issues without getting bogged down in approval for routine items that can be handled at lower levels. By distributing responsibility throughout the organization; the quality organization can retain oversight without becoming a bottleneck.
Finally, Training is necessary to ensure that standardized processes are executed consistently across the organization. Employees must understand how to execute standardized processes as well as why they are executing those processes. Initial system training should include education regarding responsibilities related to workflow as well as navigating the system. Role-based instruction is generally more effective than general demonstrations since employees need to understand what actions apply to their work. Organizational reinforcement of reasoning behind data quality, traceability and timely documentation can also prevent perception that the system is an administrative burden. User feedback can also help identify areas where too much complexity is leading to workarounds or delaying execution. Thus sustainable scale exists when Technology, Governance, Process Design and Employee Behavior all converge.
Developing a Business Case for Quality Systems Modernization
Modernizing Quality Systems is typically justified primarily on compliance grounds; however there are also other economic ramifications. Manual coordination among Quality professionals, Engineers, Manufacturing staff, Regulatory affairs and Management personnel consume costly professional time searching for documents; obtaining approvals; gathering audit information; updating spreadsheets; reconciling duplicate information; assembling status reports etc… Most of these activities do not appear as a single budget line item; however collectively they can account for substantial operating expenses. Delays in investigating issues; implementing changes; providing visibility into supplier performance can also negatively impact production continuity and release schedules for products. Therefore a scalable Quality System provides value by eliminating friction in multiple recurring activities versus providing one isolated productivity gain.
Both Direct Efficiency and Avoided Operational Risk should therefore be evaluated when considering financial justification for modernization efforts. Organizations should measure time spent maintaining quality records; preparing for audits; coordinating training; managing CAPAs; and resolving document discrepancies. Organizations should also measure costs related to delayed releases; protracted investigations of non-conforming items; scrap; rework; failed suppliers; and repetitive corrective actions. Not all benefits will lend themselves to conversion into dollar values; however the evaluation will enable leadership to understand where lack of maturity in their Quality System is impacting their business performance. In addition evaluating costs enables comparing technological investments vs. continued scaling via additional administrative personnel.
Additionally there are Strategic Implications to investments in Quality Systems Modernization. Medical Device manufacturers entering new markets; expanding manufacturing capacity; acquiring other companies; or adding product families require an infrastructure that can accommodate increasing complexity. As companies expand their reach beyond their initial markets and/or capacity; quality environments that rely on individual expertise or disparate local spreadsheet models may function during early stages of growth; but become increasingly difficult to integrate across larger enterprises. Creating Digital Processes centered around standard definitions makes it easier to onboard employees; integrate acquired operations; and develop consistent reporting mechanisms. Digital Processes also provide leadership with greater assurance that quality controls are operating correctly across the organization. Therefore scalability is now a component of Enterprise Readiness – not simply a project undertaken by the Quality Department.
Successfully Implementing a More Scalable Quality System without Disrupting Current Activities
Successful Implementation typically starts with Prioritization verses trying to overhaul every process at once. Manufacturers should first prioritize processes that present the highest degree of Compliance Risk, Administrative Burden & Operational Delay. Common areas where many manufacturers start are Document Control, Training, CAPA Non-Conformance, Change Control Complaints & Supplier Quality. The priority order will vary depending on organizational specifics. Process Mapping can identify duplicative information flow; stalled approvals due to excessive signatures; and unofficial workarounds created by employees due to inefficiencies in current processes. These findings should drive Configuration decisions and help define measurable goals for the Modernization Program. By phasing implementation efforts you minimize disruption while demonstrating tangible results sooner.
Migrating from old systems to new systems is critical because migrating bad data into a new system does not automatically create a better quality environment. Legacy Documents/Records should be analyzed for Relevance/Accuracy/Owning Organization/Retention Obligations/Duplication before importing large quantities of Records into a New System. Organizations should also identify which Historical Information truly needs to remain Actively Searchable within the new system and what can remain in an Appropriately Controlled Archive. Validated Testing should ensure that Configured Workflows/Permissions/Signed Approvals/Records/Reporting Functions operate as intended. Proper Migration builds Confidence in the New Environment and prevents Legacy Issues from hindering Future Analytics.
Ultimately Implementation Success should be measured by Adoption by End-users (employees) rather than when the Software becomes Available for Use. Users should be able to accomplish Routine Tasks with Less Uncertainty & Fewer Manual Hand-offs then previously existed. Managers should be able to quickly obtain Meaningful Status Information about their Teams/Cost Centers/etc.. Quality Staff should expend less Time reassembling Evidence for Audits/Failures/etc..
Early Metrics can Track Workflow Cycle Times/Overdue Actions/User Adoption/Audit Preparation Effort & Recurring Quality Events. Feedback should be used to Simplify Processes Where Unnecessary Friction Still Exists – while Preventing Uncontrolled Customization through Governance. Ultimately the Goal is not simply to Deploy a New Application – but Rather Create a Quality Operating System Capable of Supporting Next Stage of Manufacturing Growth.
The better question is whether the system can handle more complexity with less additional workload and related administrative burden and increased regulatory exposure. A scalable quality management system (QMMS) is designed to address this type of issue before growth occurs and expose issues in the existing model. A scalable QMMS ties together all elements of quality; i.e., people, processes, evidence, decision making, and ultimately provides a basis from which to build a quality management system to drive consistency across products, and manufacturing, with greater speed than prior systems.